Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Privacy Protections Facilitate Research Efforts, Mass. General's Koski Says

Executive Summary

Enhanced patient privacy protections are necessary to preserve the ability of institutions to conduct biomedical research, Partners HealthCare System Human Research Affairs Director Greg Koski, MD/PhD, testified before the Senate Health, Education, Labor & Pensions Committee April 26.

You may also be interested in...



Quintiles/WebMD Injunction May Clarify Privacy Rule Preemption Provisions

The preemption provision in HHS' final privacy rule will be less of a concern for companies seeking to transfer health information across state lines if the preliminary injunction in Quintiles v. WebMD is upheld, attorney Alexander Brittin told the Pharmaceutical Care Management Association March 30.

Quintiles/WebMD Injunction May Clarify Privacy Rule Preemption Provisions

The preemption provision in HHS' final privacy rule will be less of a concern for companies seeking to transfer health information across state lines if the preliminary injunction in Quintiles v. WebMD is upheld, attorney Alexander Brittin told the Pharmaceutical Care Management Association March 30.

HHS Privacy Regs Could Affect Firms' Product Support Services, BIO Says

HHS' proposed privacy rule should be amended to allow for information sharing by providers who call manufacturers' product support lines, BIO said in draft comments on the administration's proposal on the proper handling of medical records.

UsernamePublicRestriction

Register

LL016481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel